Comments

Cidara Therapeutics Stock Guidance

CDTXNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$220.19
0.590.27%
At close: Dec 11, 4:00 PM EST
$220.19
N/A
After Hours: 4:00 PM EST
OverviewNewsEarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report

Cidara Therapeutics Stock Guidance | NASDAQ:CDTX | Benzinga

Cidara Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Cidara Therapeutics Inc (CDTX) does not provide guidance data

FAQ

Q

What is the most recent guidance for Cidara Therapeutics (CDTX)?

A

There have been no specific sales or earnings guidance reported for Cidara Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Avidity Biosciences Inc
NASDAQ:RNA
$71.60
%
Cogent Biosciences Inc
NASDAQ:COGT
$40.04
%
Celcuity Inc
NASDAQ:CELC
$101.58
0.80%
Alkermes PLC
NASDAQ:ALKS
$29.17
%
PTC Therapeutics Inc
NASDAQ:PTCT
$75.89
0.60%
Protagonist Therapeutics Inc
NASDAQ:PTGX
$92.25
%
TG Therapeutics Inc
NASDAQ:TGTX
$31.84
-0.50%
Vaxcyte Inc
NASDAQ:PCVX
$44.50
-0.20%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved